国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2013年
2期
178-180
,共3页
乌司他丁%丙种球蛋白%重症肺炎
烏司他丁%丙種毬蛋白%重癥肺炎
오사타정%병충구단백%중증폐염
Ulinastatin%Gamma globulin%Severe pneumonia
目的 研究乌司他丁与丙种球蛋白联用对重症肺炎患者的疗效.方法 选择2008年3月至2012年3月我院收治的152例重症肺炎患者,按照随机数表法将所有患者随机分为实验组和对照组各76例.两组患者均予以常规治疗,对照组在此基础上采用丙种球蛋白进行治疗,实验组在对照组的基础上加用乌司他丁进行治疗.结果 治疗后,实验组患者的平均退热时间、湿啰音消退时间、呼吸衰竭纠正时间以及住院时间均明显短于对照组,差异有显著性(P<0.05);实验组患者的总有效率(89.5%)明显高于对照组(67.1%),实验组临床疗效明显优于对照组(P<0.05).结论 乌司他丁与丙种球蛋白联合治疗重症肺炎疗效显著,值得临床推广应用.
目的 研究烏司他丁與丙種毬蛋白聯用對重癥肺炎患者的療效.方法 選擇2008年3月至2012年3月我院收治的152例重癥肺炎患者,按照隨機數錶法將所有患者隨機分為實驗組和對照組各76例.兩組患者均予以常規治療,對照組在此基礎上採用丙種毬蛋白進行治療,實驗組在對照組的基礎上加用烏司他丁進行治療.結果 治療後,實驗組患者的平均退熱時間、濕啰音消退時間、呼吸衰竭糾正時間以及住院時間均明顯短于對照組,差異有顯著性(P<0.05);實驗組患者的總有效率(89.5%)明顯高于對照組(67.1%),實驗組臨床療效明顯優于對照組(P<0.05).結論 烏司他丁與丙種毬蛋白聯閤治療重癥肺炎療效顯著,值得臨床推廣應用.
목적 연구오사타정여병충구단백련용대중증폐염환자적료효.방법 선택2008년3월지2012년3월아원수치적152례중증폐염환자,안조수궤수표법장소유환자수궤분위실험조화대조조각76례.량조환자균여이상규치료,대조조재차기출상채용병충구단백진행치료,실험조재대조조적기출상가용오사타정진행치료.결과 치료후,실험조환자적평균퇴열시간、습라음소퇴시간、호흡쇠갈규정시간이급주원시간균명현단우대조조,차이유현저성(P<0.05);실험조환자적총유효솔(89.5%)명현고우대조조(67.1%),실험조림상료효명현우우대조조(P<0.05).결론 오사타정여병충구단백연합치료중증폐염료효현저,치득림상추엄응용.
Objective To study the efficacy of ulinastatin combined with gamma globulin in trPatment for patients with severe pneumonia.Methods 152 patients with seve.re.pneumonia from March 2008 to March 2012.in accordanCP with the law of thP random number table.were randomly divided into experimental group and control group,76 patients in each group.The two groups were treated with conventional therapy,the conventional treatment for severe pneumonia treatment and contml group based on gamma globulin treatment; experimental group on the basis of' the control group,was treated with ulinastatin.After the treatment,the clinical efficacy of the two groups were observed.Results After treatment,the average cooling time of the patients in the experimental group,moist rales subsided time,respiratory failure to correct time and hospital stay were significantly shorter than those of the control group,the two groups had signifieant difference (P<0.05); the experimental group patients after total efficiency (89.5%) was significantly higher than that of the control group(67.1%),the clinical efficacy of treatment of the experimental group was significantly better than that in the control group (P<0.05).Conclusion The efficacy of ulinastatin combined with gamma globulin in treatment for patients with severe pneumonia is significant,worthy of clinical application.